Xiangxue Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xiangxue Pharmaceutical Co Ltd with three other
companies in this sector in China:
Anhui Fengyuan Pharmaceutical
sales of 2.03 billion Chinese Renmimbi [US$308.58 million]
of which 63%
was Medicine Retail Circulation),
SSY Group Ltd
(2.02 billion Chinese Renmimbi [US$307.16 million]
of which 94%
was Intravenous Infusion Solution and Others), and
Guangdong Zhongsheng Pharmaceutical Co Ltd
(1.69 billion Chinese Renmimbi [US$256.82 million]
of which 93%
was Medicine Manufacture).
During the year ended December of 2016, sales at
Xiangxue Pharmaceutical Co Ltd were 1.86 billion Chinese Renmimbi (US$282.42 million).
increase of 27.2%
versus 2015, when the company's sales were 1.46 billion Chinese Renmimbi.
Sales of Other Operations saw an increase
that was more than double the company's growth rate: sales were up
748.5% in 2016, from
14.01 million Chinese Renmimbi to 118.83 million Chinese Renmimbi.
Xiangxue Pharmaceutical Co Ltd also saw significant increases in sales in
Chinese Herbal Medicines (up 57.9% to 623.94 million Chinese Renmimbi)
Pharmaceutical Distribution (up 226.8% to 518.45 million Chinese Renmimbi)
Not all segments of Xiangxue Pharmaceutical Co Ltd experienced an increase in sales in 2016:
sales of Medical Apparatus and Instruments fell 42.6% to 20.98 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Xiangxue Pharmaceutical Co Ltd also experienced decreases in sales in
Pharmaceutical Manufacturing (down 27.4% to 563.22 million Chinese Renmimbi)